Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swadesh K Das

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Expert Opinion on Therapeutic Targets|March 8, 2025
MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understandingSwadesh K Das, Paul B Fisher
Biochimica Et Biophysica Acta|January 31, 2008
Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin DSwadesh K Das, Takashi Hashimoto, Kazuki Kanazawa
The Journal of Clinical Investigation|September 16, 2025
NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistanceNarsimha Mamidi, Swadesh K Das, Paul B Fisher
Journal of Agricultural and Food Chemistry|April 28, 2010
Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cellsSwadesh K Das, Rendong Ren, Takashi Hashimoto, et al.
Advances in Cancer Research|November 16, 2025
PROTACS- targeted protein degradation as a path to precision cancer therapeuticsHannah R Gatley, Paul B Fisher, Swadesh K Das
Advances in Cancer Research|March 29, 2023
PrefaceJoseph W Landry, Swadesh K Das, Paul B Fisher
Advances in Cancer Research|March 29, 2023
Targeting epigenetic regulation for cancer therapy using small molecule inhibitorsAmit Kumar, Luni Emdad, Paul B Fisher, et al.
Advances in Cancer Research|July 28, 2019
MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasisSwadesh K Das, Devanand Sarkar, Luni Emdad, et al.
Tissue Barriers|October 15, 2021
GAP junctions: multifaceted regulators of neuronal differentiationSarmistha Talukdar, Luni Emdad, Swadesh K Das, et al.
Advances in Cancer Research|June 29, 2020
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cellsSarmistha Talukdar, Luni Emdad, Swadesh K Das, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Expert Opinion on Therapeutic Targets|March 8, 2025
MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understandingSwadesh K Das, Paul B Fisher
Biochimica Et Biophysica Acta|January 31, 2008
Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin DSwadesh K Das, Takashi Hashimoto, Kazuki Kanazawa
The Journal of Clinical Investigation|September 16, 2025
NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistanceNarsimha Mamidi, Swadesh K Das, Paul B Fisher
Journal of Agricultural and Food Chemistry|April 28, 2010
Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cellsSwadesh K Das, Rendong Ren, Takashi Hashimoto, et al.
Advances in Cancer Research|November 16, 2025
PROTACS- targeted protein degradation as a path to precision cancer therapeuticsHannah R Gatley, Paul B Fisher, Swadesh K Das
Advances in Cancer Research|March 29, 2023
PrefaceJoseph W Landry, Swadesh K Das, Paul B Fisher
Advances in Cancer Research|March 29, 2023
Targeting epigenetic regulation for cancer therapy using small molecule inhibitorsAmit Kumar, Luni Emdad, Paul B Fisher, et al.
Advances in Cancer Research|July 28, 2019
MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasisSwadesh K Das, Devanand Sarkar, Luni Emdad, et al.
Tissue Barriers|October 15, 2021
GAP junctions: multifaceted regulators of neuronal differentiationSarmistha Talukdar, Luni Emdad, Swadesh K Das, et al.
Advances in Cancer Research|June 29, 2020
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cellsSarmistha Talukdar, Luni Emdad, Swadesh K Das, et al.
Pageof 16